From biosimilars to PLAs: Panel addresses hot topics in drug plan management
Source: Benefits Canada | Author: Michael McKiernan | January 10, 2018
From the article:
From biosimilars to product listing agreements, a panel of experts tackled some of the hottest topics in drug plan management at the Face to Face Drug Plan Management forum on Dec. 14.
